Filing Flows

Filing Flows › Materials › Ingevity (NGVT)

Ingevity (NGVT) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Ingevity (NGVT) Q3 2026 earnings results →

Q3 2026 Revenue down 8% year over year to $305M · 16¢ of every $1 of revenue kept as net profit · operating margin 22.0%

Ingevity made $305M in Q3 2026 (-8% Y/Y): Performance Materials $154M, Pavement Technologies Segment $106M, Advanced Polymer Technologies segment $45.0M. Operating margin 22.0%, net earnings $49.3M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$305M
Year over year-8%
Operating margin22.0%
Net earnings$49.3M
Operating cash flow$99.2M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $305.1M in Q3 2026, down 8% year over year and down 3% from the previous quarter. Performance Materials was the largest line at 51% of revenue. Pavement Technologies Segment lost $33.9M year over year (down 24%), 121% of the total change.

Gross margin was 43.5%, up 3.3 points from Q3 2025. Operating profit was $67.1M, a 22.0% margin (up 2.5 points year over year). Operating expenses fell 5% while revenue fell 8%. The fastest-growing cost line was Research & development (+19%). Net earnings were $49.3M, up 13% year over year. The effective tax rate was 26.5%.

Operating cash flow was $99.2M (down 24% year over year), 201% of net earnings. Non-cash charges added back $20.9M of depreciation and amortization and $4.0M of share-based compensation. Working capital and other items added $25.0M. After capital expenditures ($13.7M), free cash flow as the company reports it was $85.5M.

Quarterly history

Ingevity revenue by quarterIngevity revenue by quarter$284MQ1 2025$365MQ2 2025$333MQ3 2025$255MQ4 2025$258MQ1 2026$314MQ2 2026$305MQ3 2026
Ingevity net earnings by quarterIngevity net earnings by quarter$20.5MQ1 2025−$146MQ2 2025$43.5MQ3 2025−$84.6MQ4 2025$59.8MQ1 2026$35.3MQ2 2026$49.3MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$305M-8%22.0%$49.3M$99.2M
Q2 202610-QJul 30, 2026$314M-5%14.7%$35.3M−$13.8M
Q1 202610-QMay 7, 2026$258M+4%25.8%$59.8M−$2.0M
Q4 202510-KFeb 26, 2026$255M-3%-43.6%−$84.6M$97.1M
Q3 202510-QNov 6, 2025$333M-0.2%19.5%$43.5M$130M
Q2 202510-QAug 5, 2025$365M-6%-39.1%−$146M$79.0M
Q1 202510-QMay 6, 2025$284M-16%9.4%$20.5M$25.4M

Charts

Ingevity: revenue growth, year over year and quarter over quarterIngevity: revenue growth, year over year and quarter over quarterY/YQ/Q-16%Q1 2025-6%+29%Q2 20250%-9%Q3 2025-3%-23%Q4 2025+4%+1%Q1 2026-5%+22%Q2 2026-8%-3%Q3 2026
Latest (Q3 2026): Y/Y -8%, Q/Q -3%.
Ingevity: where the cash came from (+) and went (−), TTM to Q3 2026Ingevity: where the cash came from (+) and went (−), TTM to Q3 2026Other financing−$1.1BNet borrowing (+) / repaid (−)$1.0BOther investing$213MOperating cash flow$180MBuybacks−$156MCash drawn (+) / kept (−)−$58.0MCapital spending−$57.9MTaxes on employees’ shares−$7.2MShares issued$7.0MNot reconciled−$1.4M
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Ingevity: profit against cash, quarter by quarterIngevity: profit against cash, quarter by quarterNet incomeOperating cash flow$16.6M$64.5MQ4 2024$20.5M$25.4MQ1 2025−$146M$79.0MQ2 2025$43.5M$130MQ3 2025−$84.6M$97.1MQ4 2025$59.8M−$2.0MQ1 2026$35.3M−$13.8MQ2 2026$49.3M$99.2MQ3 2026
Latest (Q3 2026): Net income $49.3M, Operating cash flow $99.2M.
Ingevity: diluted shares by fiscal yearIngevity: diluted shares by fiscal year42MFY202040MFY202138MFY202237MFY202336MFY202436MFY2025
-12.8% since FY2020: buybacks shrank the count.
Ingevity in its industry: growth against margin (16 companies, SIC 2800)Ingevity in its industry: growth against margin (16 companies, SIC 2800)revenue growth, year over year →↑ operating marginmedian +8%median 9%OLNHUNHuntsman International LLCCCSOLSIOSPPRMECVTBCPCFMCACNTGUREBLGOCITRLQMTNGVT (-8%, 22%)
Chemicals & Allied Products; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Ingevity

Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, and bring to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable. Our products are used in a variety of demanding applications, including automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings. We operate in three reportable segments: Performance Materials, Performance Chemicals and Advanced Polymer Technologies.

In its own words, from its 10-K, filed Feb 26, 2026.

Ingevity against its Chemicals & Allied Products peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -8% against the peers' median +8%. Operating margin: 22.0% against the peers' median 9.5%.

CompanyQuarterRevenueY/YOp. margin
NGVT IngevityQ3 2026$305M-8%22.0%
OLN OlinQ3 2026$1.7B+2%3.4%
HUN HuntsmanQ3 2026$1.7B+18%2.3%
Huntsman International LLCQ2 2026$1.7B+14%2.2%
CC ChemoursQ3 2026$1.5B+3%14.4%
SOLS Solstice Advanced MaterialsQ3 2026$1.0B+8%10.7%
IOSP InnospecQ3 2026$474M+7%8.8%
PRM Perimeter GroupQ3 2026$390M+24%106.8%
ECVT EcovystQ3 2026$309M+51%9.5%

Source: Ingevity 10-Q on SEC EDGAR · CIK 1653477 · Chemicals & Allied Products

Guidance and outlook

Ingevity: what its forward-looking statements are about (10-Q filed 2026-11-05)Ingevity: what its forward-looking statements are about (10-Q filed 2026-11-05)Demand6Other3Deals2Costs2Tax2Capital spending2Financing2Supply chain1People1
21 statements; tone +0.33 (−1 all cautious, +1 all confident); 4 hedged.
Ingevity: outlook statements against the filing beforeIngevity: outlook statements against the filing beforeConfident9Cautious2

13F: who owns NGVT and who is buying

Largest holders of NGVT (13F)Largest holders of NGVT (13F)BlackRock$401MVanguard Group$238MVanguard Portfolio Management LLC$177MVanguard Capital Management LLC$117MState Street$112MAmerican Century Companies$94.9MWellington Management Group LLP$80.3MMillennium Management LLC$74.1MBrown Advisory$72.7MRoyce & Associates LP$70.2M
Funds' net buying of NGVT by quarter (13F)Funds' net buying of NGVT by quarter (13F)$18.5M2024-09$20.5M2024-12$41.8M2025-03$18.2M2025-06−$46.6M2025-09$52.5M2025-12−$83.7M2026-03−$60.3M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on NGVT

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare NGVT with

中文版：Ingevity（NGVT）财报

Español · Français